PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $73,000 | -9.9% | 23,284 | -16.5% | 0.00% | – |
| Q2 2020 | $81,000 | +2.5% | 27,872 | 0.0% | 0.00% | – |
| Q1 2020 | $79,000 | -28.8% | 27,872 | -18.0% | 0.00% | – |
| Q4 2019 | $111,000 | +52.1% | 33,970 | 0.0% | 0.00% | – |
| Q3 2019 | $73,000 | -7.6% | 33,970 | +35.1% | 0.00% | – |
| Q2 2019 | $79,000 | -24.8% | 25,136 | -11.0% | 0.00% | – |
| Q1 2019 | $105,000 | +36.4% | 28,236 | +5.8% | 0.00% | – |
| Q4 2018 | $77,000 | +37.5% | 26,678 | +24.2% | 0.00% | – |
| Q3 2018 | $56,000 | +12.0% | 21,481 | 0.0% | 0.00% | – |
| Q2 2018 | $50,000 | -38.3% | 21,481 | -22.3% | 0.00% | – |
| Q1 2018 | $81,000 | -23.6% | 27,659 | -27.4% | 0.00% | – |
| Q4 2017 | $106,000 | -29.8% | 38,085 | -14.4% | 0.00% | – |
| Q3 2017 | $151,000 | +49.5% | 44,487 | +10.8% | 0.00% | – |
| Q2 2017 | $101,000 | -15.8% | 40,151 | -25.2% | 0.00% | – |
| Q1 2017 | $120,000 | -80.7% | 53,700 | -81.7% | 0.00% | -100.0% |
| Q4 2016 | $622,000 | -33.5% | 293,356 | +4.7% | 0.00% | 0.0% |
| Q3 2016 | $935,000 | +47.9% | 280,214 | +38.9% | 0.00% | 0.0% |
| Q2 2016 | $632,000 | +24.2% | 201,737 | +31.7% | 0.00% | 0.0% |
| Q1 2016 | $509,000 | -14.2% | 153,167 | -8.6% | 0.00% | 0.0% |
| Q4 2015 | $593,000 | +8.0% | 167,504 | +53.4% | 0.00% | 0.0% |
| Q3 2015 | $549,000 | -21.8% | 109,166 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $702,000 | -3.7% | 109,166 | +5.6% | 0.00% | 0.0% |
| Q1 2015 | $729,000 | +16.8% | 103,357 | +27.8% | 0.00% | 0.0% |
| Q4 2014 | $624,000 | +3.5% | 80,845 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $603,000 | +11.7% | 80,503 | +44.3% | 0.00% | 0.0% |
| Q2 2014 | $540,000 | +16.4% | 55,786 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $464,000 | -1.5% | 55,786 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $471,000 | +5.8% | 55,786 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $445,000 | +127.0% | 55,786 | +119.8% | 0.00% | – |
| Q2 2013 | $196,000 | – | 25,381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |